Milad Alucozai, DrPH

Dr. Milad Alucozai, recognised by Business Insider as “one of the top 100 early-stage investors”, is a neuroscientist, founder, and active investor dedicated to translating exceptional science and technology into scalable commercial ventures. He currently serves as a Co-founder and General Partner at Pamir Ventures, an early-stage venture fund that invests in technical pioneers developing B2B companies utilising AI in antiquated industries. He is also a co-founder of Revalia Bio, a leading AI company enabling “Human Data Trials” to accelerate drug development with real human data before the first clinical trial begins. Throughout his operating and investing career, Milad has played a crucial role in helping founders secure hundreds of millions in capital and facilitating billions in startup-pharma partnerships.